Citation:Medical Research Council Lung Cancer Working Party. 1992

From Cancer Guidelines Wiki

Citation


Medical Research Council Lung Cancer Working Party.. A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Working Party. Br J Cancer 1992;65(6):934-941. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1377484.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the clinical benefit of radiotherapy to the lung primary in stage IV NSCLC?Associate Professor Shalini Vinod MBBS MD FRANZCRcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the clinical benefit of radiotherapy to the lung primary in Stage IV NSCLC?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the clinical benefit of radiotherapy to the lung primary in Stage IV NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Emma.dickins/Sandbox
  2. What is the clinical benefit of radiotherapy to the lung primary in stage IV NSCLC?